Recent studies have pointed out that CAF promotes the reduction of the amount of CD8 + T cells and the improvement of tumor cell survival capability by inducing the expression of immune checkpoints in an indirect manner, thereby achieving the effect of weakening the antitumor response of effector T cells (229, 245, 282). The gene discussed is CD8A; the disease is neoplasm.